Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

@inproceedings{Bo2018TumorinfiltratingMC,
  title={Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients},
  author={Xiaobo Bo and Jiejun Wang and Tao Suo and Xiaoling Ni and Han Liu and Sheng Min Shen and Min Li and Yueqi Wang and Houbao Liu and Jiejie Xu},
  booktitle={BMC Cancer},
  year={2018}
}
Recent studies have reported TIMs play an important role in tumors progression or regression, but the effect of TIMs in biliary tract cancer remains unclear. The aim of this study is to investigate the prognostic value of tumor infiltrating mast cells (TIMs) and its influence on gemcitabine-based adjuvant chemotherapy (ACT) benefits in biliary tract cancer… CONTINUE READING